BioTransplant to acquire Eligix

CHARLESTOWN — BioTransplant, Inc., based here, has agreed to acquire Eligix, Inc. of Medford in a stock transaction valued at $55.3 million, the Boston Globe reported. BioTransplant is a developer of organ transplant drugs. Eligix is a medical equipment company. Walter C. Ogier, the founder and chief executive of Eligix will become president of BioTransplant where Elliott Lebowitz will remain as chairman and chief executive. Lebowitz is reported by the Globe to have said all 30 Eligix employees will be retained by BioTransplant, which is also acquiring Eligix’s pharmaceutical plant in Medford.